Revolution Medicines, Inc.RVMD

Market cap

$14.7B

P/E ratio

	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	105	110	163	699	543
Marketable securities, current	336	469	484	1,157	1,746
Total cash & short-term investments	442	579	647	1,856	2,289
Total current assets	454	590	660	1,879	2,328
Property, plant and equipment, net	9	12	19	23	24
Total non-current assets	113	148	152	182	231
Total assets	567	738	812	2,062	2,558
Accounts payable	13	14	21	62	54
Total current liabilities	47	60	62	144	164
Total non-current liabilities	46	75	65	92	129
Total liabilities	93	135	127	236	293
Common stock and paid-in capital	0	0	0	0	0
Retained earnings	-266	-453	-701	-1,100	-1,700
Stockholders' equity	475	603	685	1,826	2,265